Indiana § 12-15-35-31 Intervention; approval; requisites

Indiana Statutes

§ 12-15-35-31 — Intervention; approval; requisites

Indiana·Art. 15 MEDICAID·Ch. 35 Drug Utilization Review

(a)An intervention developed under section 28(a)(4) of this chapter that involves a physician must be approved by at least three (3) of the four (4) physician members of the board before implementation.

(b)An intervention that involves a pharmacist must be approved by at least three (3) of the four (4) pharmacist members of the board before implementation.

(c)Interventions include the following:

(1)Information disseminated to physicians and pharmacists to ensure that physicians and pharmacists are aware of the board's duties and powers.

(2)Written, oral, or electronic reminders of recipient-specific or drug-specific information that are designed to ensure recipient, physician, and pharmacist confidentiality, and suggested changes in the prescribing or dispensing practices designed to

Free access — add to your briefcase to read the full text and ask questions with AI

(a) An intervention developed under
section 28(a)(4) of this chapter that involves a physician must be
approved by at least three (3) of the four (4) physician members of the
board before implementation.
(b) An intervention that involves a pharmacist must be approved by
at least three (3) of the four (4) pharmacist members of the board
before implementation.
(c) Interventions include the following:
(1) Information disseminated to physicians and pharmacists to
ensure that physicians and pharmacists are aware of the board's
duties and powers.
(2) Written, oral, or electronic reminders of recipient-specific or
drug-specific information that are designed to ensure recipient,
physician, and pharmacist confidentiality, and suggested changes
in the prescribing or dispensing practices designed to improve the
quality of care.
(3) Use of face-to-face discussions between experts in drug
therapy and the prescriber or pharmacist who has been targeted
for educational intervention.
(4) Intensified reviews or monitoring of selected prescribers or
pharmacists.
(5) The creation of an educational program using data provided
through DUR to provide for active and ongoing educational
outreach programs to improve prescribing and dispensing
practices.
(6) The timely evaluation of interventions to determine if the
interventions have improved the quality of care.
(7) The review of case profiles before the conducting of an
intervention.